Gertrude Nieuwenhuijs-Moeke is a consultant anesthesiologist for abdominal, oncological and transplant surgery at the University Medical Center Groningen in Groningen, the Netherlands. She performes clinical and translational research with focus on: ischemia and reperfusion injury and strategies to reduce injury and improve preservation and repair in kidney transplantation, anesthesia and the immune system and perioperative organ and patient protective strategies. She is a member of the scientific committee of the international meeting of ischemia and reperfusion injury in transplantation (IMIRT), the local scientific committee of kidney transplantation in the UMCG and involved in several research projects. She designed, organised and executed the VAPOR-1 Trial, a single center RCT (Vapor-1 trial, BJA 2017), and organised the participation of Erasmus Medical Center Rotterdam and University Medical Centre Groningen in the CONTEXT trial, a Danish multicenter RCT looking at the effect of remote ischemic conditioning on outcome in renal transplantation using kidneys from deceased donors (Context trial, AJT 2016). She is the project leader and PI of the VAPOR-2 Trial (ClinicalTrials.gov: NCT02727296), an international multicenter study on the effect of a sevoflurane based anesthesia versus a propofol based anesthesia on the incidence of DGF in recipients of kidneys of donation after circulatory death (DCD) and donation after brain death (DBD) donors.